RE:RE:RE:Deals Done?Ok, I have the facts correct, from Amorfix archives PR August 3, 2006. "Amorfix announced today that it has entered into a research and investment agreement with Biogen". "On closing, Biogen Idec subscribed for common shares of Amorfix in the amount of US $ 375,000 representing 289,187 common shares at a price of Cdn $ 1.46 per common share.